Dexcom
The announcement comes less than a year after Dexcom announced a strategic partnership and $75 million investment in the health-tracking ring maker.
The G7 continuous glucose monitoring system will have a 15.5-day wear time and last 15% longer than Dexcom G7, according to the company.
The company's SimpleSense wearable will ingest glucose data from the Dexcom G7 continuous glucose monitor system.
Jake Leach, executive VP and chief operating officer at Dexcom, joined MobiHealthNews to discuss the company's evolution and offerings beyond diabetes.
The investment brings Oura's valuation to more than $5 billion. The partnership enables a two-way data flow between the Oura Ring and Dexcom's continuous glucose monitor.
The t:slim X2 Pump is compatible with Dexcom G7 and G6 continuous glucose monitoring systems and was cleared for sale by Health Canada.
The feature allows users to obtain real-time CGM data on their Watch without an iPhone present.
The patch provides continuous glucose monitoring, sends readings directly to a wearer's smartphone and supplies personal insights into one's glucose health.
Also, the mental health app Here Hear in Taiwan is set to introduce an AI chatbot.
The CGM-based service will begin in Q4.